On the heels of a clinical setback for Bristol Myers Squibb’s schizophrenia newcomer Cobenfy, the New Jersey pharma is ...

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...

These doctors diagnose and specialize in the treatment of schizophrenia and other mental, emotional, or behavioral problems. They can prescribe medications and do “talk therapy.” They can’t ...